| AD | Alzheimer’s disease |
| ASCT1 | Alanine-serine-cysteine transporter 1 |
| BBB | Blood–Brain Barrier |
| CSF | Cerebrospinal fluid |
| D-ser | Dextro (D)-serine |
| FAD | Familial Alzheimer’s Disease |
| GluN2 | Glutamate ionotrophic receptor NMDA type subunit 2 |
| GluN3 | Glutamate ionotrophic receptor NMDA type subunit 3 |
| KOMP | Knockout Mouse Project |
| L-DOPA | Levodopa |
| L-ser | Levo (L)-serine |
| LTP | Long-term potentiation |
| MDD | Major Depressive Disorder |
| NMDA | N-methyl-D-aspartate |
| PD | Parkinson’s disease |
| PCP | Phencyclidine |
| PHGDH | Phosphoglycerate dehydrogenase |
| SLC1A4 | Solute carrier family 1 member 4 gene |
| SLC1A4 | Solute carrier family 1 member 4 protein |
| SNP | Single nucleotide polymorphism |
| SPATCCM | Spastic tetraplegia, thin corpus callosum and progressive microcephaly |
| TBI | Traumatic Brain Injury |